These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19767013)

  • 41. Platelet paroxetine binding in post-traumatic stress disorder.
    Maguire K; Norman T; Burrows G; Hopwood M; Morris P
    Psychiatry Res; 1998 Jan; 77(1):1-7. PubMed ID: 10710169
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The 5HTTLPR polymorphism, psychopathologic symptoms, and platelet [3H-] paroxetine binding in bulimic syndromes.
    Steiger H; Joober R; Israël M; Young SN; Ng Ying Kin NM; Gauvin L; Bruce KR; Joncas J; Torkaman-Zehi A
    Int J Eat Disord; 2005 Jan; 37(1):57-60. PubMed ID: 15690467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study.
    Meyer JH; Wilson AA; Ginovart N; Goulding V; Hussey D; Hood K; Houle S
    Am J Psychiatry; 2001 Nov; 158(11):1843-9. PubMed ID: 11691690
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Platelet serotonin, monoamine oxidase activity, and [3H]paroxetine binding related to impulsive suicide attempts and borderline personality disorder.
    Verkes RJ; Van der Mast RC; Kerkhof AJ; Fekkes D; Hengeveld MW; Tuyl JP; Van Kempen GM
    Biol Psychiatry; 1998 May; 43(10):740-6. PubMed ID: 9606528
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relationship of the serotonin transporter with prolactin response to meta-chlorophenylpiperazine in cocaine dependence.
    Patkar AA; Mannelli P; Peindl K; Hill KP; Wu LT; Lee T; Kuhn C
    J Psychiatr Res; 2008 Oct; 42(14):1213-9. PubMed ID: 18321529
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Salivary cortisol awakening levels are reduced in human subjects with intermittent explosive disorder compared with controls.
    Meruelo AD; Timmins MA; Irwin MR; Coccaro EF
    Psychoneuroendocrinology; 2023 May; 151():106070. PubMed ID: 36863129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Childhood abuse and platelet tritiated-paroxetine binding in bulimia nervosa: implications of borderline personality disorder.
    Steiger H; Léonard S; Kin NY; Ladouceur C; Ramdoyal D; Young SN
    J Clin Psychiatry; 2000 Jun; 61(6):428-35. PubMed ID: 10901341
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-harm behavior among individuals with intermittent explosive disorder and personality disorders.
    Jenkins AL; McCloskey MS; Kulper D; Berman ME; Coccaro EF
    J Psychiatr Res; 2015 Jan; 60():125-31. PubMed ID: 25300440
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rat strain differences in peripheral and central serotonin transporter protein expression and function.
    Fernandez F; Sarre S; Launay JM; Aguerre S; Guyonnet-Dupérat V; Moisan MP; Ebinger G; Michotte Y; Mormède P; Chaouloff F
    Eur J Neurosci; 2003 Feb; 17(3):494-506. PubMed ID: 12581167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers.
    McCloskey MS; Ben-Zeev D; Lee R; Berman ME; Coccaro EF
    Psychopharmacology (Berl); 2009 Mar; 203(1):53-61. PubMed ID: 18946662
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Reduced platelet [3H]paroxetine binding in anorexia nervosa: relationship to eating symptoms and personality pathology.
    Bruce KR; Steiger H; Ng Ying Kin NM; Israel M
    Psychiatry Res; 2006 Jun; 142(2-3):225-32. PubMed ID: 16697471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    Meyer JH; Wilson AA; Sagrati S; Hussey D; Carella A; Potter WZ; Ginovart N; Spencer EP; Cheok A; Houle S
    Am J Psychiatry; 2004 May; 161(5):826-35. PubMed ID: 15121647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between 5-HT function and impulsivity and aggression in male offenders with personality disorders.
    Dolan M; Anderson IM; Deakin JF
    Br J Psychiatry; 2001 Apr; 178():352-9. PubMed ID: 11282815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of DSM-IV intermittent explosive disorder in Black adolescents: Findings from the National Survey of American Life, Adolescent Supplement.
    Oliver DG; Caldwell CH; Faison N; Sweetman JA; Abelson JM; Jackson JS
    Am J Orthopsychiatry; 2016; 86(5):552-63. PubMed ID: 27078052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intermittent Explosive Disorder and Substance Use Disorder: Analysis of the National Comorbidity Survey Replication Sample.
    Coccaro EF; Fanning JR; Lee R
    J Clin Psychiatry; 2017 Jun; 78(6):697-702. PubMed ID: 28252880
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differences in platelet serotonin transporter sites between African-American tobacco smokers and non-smokers.
    Patkar AA; Gopalakrishnan R; Berrettini WH; Weinstein SP; Vergare MJ; Leone FT
    Psychopharmacology (Berl); 2003 Mar; 166(3):221-7. PubMed ID: 12589524
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Differential serotonin transporter (5-HTT) and 5-HT
    Brandenburg C; Blatt GJ
    J Neurochem; 2019 Dec; 151(5):642-655. PubMed ID: 31325179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Intermittent explosive disorder: current status].
    Amara G; Richa S; Baylé FJ
    Encephale; 2007; 33(3 Pt 1):339-45. PubMed ID: 17675932
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Patients with carcinoid syndrome exhibit symptoms of aggressive impulse dysregulation.
    Russo S; Boon JC; Kema IP; Willemse PH; den Boer JA; Korf J; de Vries EG
    Psychosom Med; 2004; 66(3):422-5. PubMed ID: 15184706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Validation of the Interview Module for Intermittent Explosive Disorder (M-IED) in children and adolescents: a pilot study.
    Olvera RL; Pliszka SR; Konyecsni WM; Hernandez Y; Farnum S; Tripp RF
    Psychiatry Res; 2001 Apr; 101(3):259-67. PubMed ID: 11311929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.